Consensus statements for medical practice: Biological agents and lung disease [Abridged English translation by the Japanese Respiratory Society]

Respir Investig. 2017 May;55(3):229-251. doi: 10.1016/j.resinv.2017.01.002. Epub 2017 Mar 29.
No abstract available

Keywords: Airway disease; Biological agent; Interstitial lung disease; Lung complication; Rheumatoid arthritis.

Publication types

  • Review

MeSH terms

  • Arthritis, Rheumatoid / drug therapy
  • Arthritis, Rheumatoid / epidemiology
  • Arthritis, Rheumatoid / immunology
  • Biological Factors / administration & dosage
  • Biological Factors / pharmacology
  • Biological Factors / therapeutic use*
  • Comorbidity
  • Humans
  • Japan
  • Lung Diseases / drug therapy*
  • Lung Diseases / epidemiology
  • Lung Diseases / immunology
  • Molecular Targeted Therapy*
  • Prognosis

Substances

  • Biological Factors